A detailed history of Forefront Analytics, LLC transactions in Nkarta, Inc. stock. As of the latest transaction made, Forefront Analytics, LLC holds 17,646 shares of NKTX stock, worth $41,468. This represents 0.04% of its overall portfolio holdings.

Number of Shares
17,646
Previous 11,833 49.13%
Holding current value
$41,468
Previous $69,000 14.49%
% of portfolio
0.04%
Previous 0.03%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.52 - $8.0 $26,274 - $46,504
5,813 Added 49.13%
17,646 $79,000
Q2 2024

Aug 14, 2024

BUY
$5.27 - $10.82 $62,359 - $128,033
11,833 New
11,833 $69,000
Q4 2023

Feb 13, 2024

SELL
$1.31 - $6.6 $24,745 - $124,674
-18,890 Reduced 47.63%
20,767 $137,000
Q3 2023

Nov 07, 2023

BUY
$1.39 - $2.29 $40,713 - $67,074
29,290 Added 282.53%
39,657 $55,000
Q2 2023

Aug 11, 2023

SELL
$2.19 - $5.17 $236 - $558
-108 Reduced 1.03%
10,367 $22,000
Q1 2023

May 11, 2023

BUY
$3.37 - $6.3 $35,300 - $65,992
10,475 New
10,475 $37,000

Others Institutions Holding NKTX

About Nkarta, Inc.


  • Ticker NKTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,656,800
  • Market Cap $114M
  • Description
  • Nkarta, Inc., a a clinical-stage biopharmaceutical company, develops and commercializes cell therapies for cancer treatment. The company's approach for cellular immunotherapy involves chimeric antigen receptors on the surface of a natural killer (NK) cell that enable the cell to recognize specific proteins or antigens that are present on the sur...
More about NKTX
Track This Portfolio

Track Forefront Analytics, LLC Portfolio

Follow Forefront Analytics, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forefront Analytics, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Forefront Analytics, LLC with notifications on news.